Tenofovir alafenamide fumarate

This classification denotes a reverse transcriptase inhibitor and purine antagonist 2C21H29N6O5P.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FWF6Q91TZO, chemically known as l-alanine, n-((s)-(((1r)-2-(6-amino-9h-purin-9-yl)-1-methylethoxy)methyl)phenoxyphosphinyl)-, 1-methylethyl ester, (2e)-2-butenedioate (2:1), but more generally known as tenofovir alafenamide fumarate, which bears US NIH Compound Identifier 71301443. Most nations, for tariff and trade purposes, schedule tenofovir alafenamide fumarate under HS 29335995 and SITC 51576. As of Q4 2014, TENOFOVIR ALAFENAMIDE FUMARATE remains US FDA's Preferred Term for this commodity. SMILES: C[C@H](CN1CNC2C1NCNC2N)OC[P@@](=O)(N[C@@H](C)C(=O)OC(C)C)OC3CCCCC3.C[C@H](CN1CNC2C1NCNC2N)OC[P@@](=O)(N[C@@H](C)C(=O)OC(C)C)OC3CCCCC3.C(=C/C(=O)O)\C(=O)O.